18,120 Shares in Addus HomeCare Corporation $ADUS Bought by Aurora Investment Counsel

Aurora Investment Counsel bought a new stake in shares of Addus HomeCare Corporation (NASDAQ:ADUS - Free Report) in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 18,120 shares of the company's stock, valued at approximately $1,821,000. Aurora Investment Counsel owned approximately 0.10% of Addus HomeCare as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors have also recently modified their holdings of the company. Oregon Public Employees Retirement Fund boosted its stake in Addus HomeCare by 2.5% during the 4th quarter. Oregon Public Employees Retirement Fund now owns 4,153 shares of the company's stock valued at $446,000 after purchasing an additional 103 shares during the last quarter. ProShare Advisors LLC boosted its position in shares of Addus HomeCare by 3.1% during the fourth quarter. ProShare Advisors LLC now owns 3,527 shares of the company's stock valued at $379,000 after buying an additional 105 shares during the last quarter. CANADA LIFE ASSURANCE Co increased its holdings in Addus HomeCare by 0.6% in the 2nd quarter. CANADA LIFE ASSURANCE Co now owns 18,684 shares of the company's stock worth $2,150,000 after buying an additional 106 shares in the last quarter. State of Wyoming increased its holdings in Addus HomeCare by 25.7% in the 4th quarter. State of Wyoming now owns 523 shares of the company's stock worth $56,000 after buying an additional 107 shares in the last quarter. Finally, Private Trust Co. NA raised its position in Addus HomeCare by 65.5% in the 4th quarter. Private Trust Co. NA now owns 283 shares of the company's stock worth $30,000 after buying an additional 112 shares during the last quarter. Hedge funds and other institutional investors own 95.35% of the company's stock.

Insider Activity at Addus HomeCare

In other news, insider Heather Brianne Dixon sold 288 shares of Addus HomeCare stock in a transaction on Monday, June 22nd. The stock was sold at an average price of $93.77, for a total value of $27,005.76. Following the transaction, the insider directly owned 44,371 shares in the company, valued at approximately $4,160,668.67. This trade represents a 0.64% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Corporate insiders own 4.10% of the company's stock.

Addus HomeCare Stock Up 1.6%

Shares of ADUS opened at $120.02 on Thursday. The stock has a market capitalization of $2.24 billion, a price-to-earnings ratio of 21.06, a price-to-earnings-growth ratio of 1.59 and a beta of 0.87. Addus HomeCare Corporation has a 1 year low of $87.95 and a 1 year high of $124.43. The business's 50 day simple moving average is $108.37 and its 200-day simple moving average is $102.25. The company has a debt-to-equity ratio of 0.05, a current ratio of 1.69 and a quick ratio of 1.69.

Addus HomeCare (NASDAQ:ADUS - Get Free Report) last released its quarterly earnings results on Monday, August 3rd. The company reported $1.73 EPS for the quarter, topping the consensus estimate of $1.70 by $0.03. Addus HomeCare had a return on equity of 9.96% and a net margin of 7.13%.The company had revenue of $377.41 million during the quarter, compared to analyst estimates of $376.24 million. During the same quarter last year, the business posted $1.49 earnings per share. The firm's revenue was up 8.0% on a year-over-year basis. As a group, equities analysts expect that Addus HomeCare Corporation will post 6.29 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

ADUS has been the topic of a number of research reports. Citigroup restated a "market outperform" rating on shares of Addus HomeCare in a research note on Friday, July 24th. Weiss Ratings upgraded Addus HomeCare from a "hold (c-)" rating to a "hold (c)" rating in a research report on Thursday, July 9th. Citizens Jmp reissued a "market outperform" rating and issued a $142.00 target price on shares of Addus HomeCare in a report on Monday, May 18th. Barclays raised their target price on Addus HomeCare from $92.00 to $96.00 and gave the stock an "underweight" rating in a research report on Wednesday, July 8th. Finally, Royal Bank Of Canada boosted their price target on Addus HomeCare from $130.00 to $134.00 and gave the company an "outperform" rating in a research note on Wednesday, August 5th. One investment analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average price target of $130.88.

Addus HomeCare Company Profile

Addus HomeCare NASDAQ: ADUS is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients' independence and quality of life.

The company's core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source